MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-12-0002150
Aries Drugs Private Limited - healthcare in Rudrapur, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.58 Cr
▼ 23% YoY
Net loss · FY 2024
₹26.95 Lakh
Net margin -10.5%
EBITDA · FY 2024
-₹8.38 Lakh
EBITDA margin -3.3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹87.25 Lakh
Issued & subscribed
Satisfied charges
₹45 Lakh
No open charges
Company age
21 yrs
Est. 2005
Employees · EPFO
21
Provident fund records
About Aries Drugs Private Limited
Data last updated:
Aries Drugs Private Limited is a private limited company based in Rudrapur, Uttarakhand, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 04 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24232UR2005PTC007478. Its GSTIN is 05AAFCA6166P1Z9 (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹87.25 Lakh. It is led by directors including Amit Agarwal (Managing Director) and Madan Lal Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 90 Sector I.I.D.C. Sidcul I.I.E. Pant Nagar, Rudrapur, Uttarakhand, India – 263145.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.58 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net loss of ₹26.95 Lakh (net margin -10.5%) and EBITDA of -₹8.38 Lakh (EBITDA margin -3.3%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 3% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aries Drugs. As per MCA filings, the company has satisfied charges of ₹45 Lakh on record. Court records list 26 cases involving the company, including 9 filed by the company and 17 filed against it; 6 cases are pending.
Aries Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-12-0002150). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ariesdrugs.com.
Company details
CIN U24232UR2005PTC007478
Registration Number 007478
Incorporation Date 04 April 2005
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UK-12-0002150
CIN history
Aries Drugs has one previous CIN (Corporate Identification Number): U24232UP2005PTC029733. The current CIN is U24232UR2005PTC007478, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232UR2005PTC007478 | Current |
| U24232UP2005PTC029733 | Previous |
Recognitions & Rankings of Aries Drugs
Contact details
Aries Drugs Private Limited's registered office is in Rudrapur, Uttarakhand. Its website is ariesdrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 90 Sector I.I.D.C. Sidcul I.I.E. Pant Nagar, Rudrapur, Uttarakhand, India – 263145
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Aries Drugs Private Limited, buy the company report.
Comprehensive company report
Aries Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Aries Drugs operates one associated brand: Aries Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical products for the market. | ariesdrugs.com |
Business activity
The main business activities of Aries Drugs are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aries Drugs Private Limited, buy the company report.
Financials of Aries Drugs Private Limited
FY 2024 filings availableAries Drugs Private Limited reported revenue of ₹2.58 Cr (down 23% YoY) for FY 2024.
Revenue · FY 2024
₹2.58 Cr ▼ 23%
Net loss · FY 2024
₹26.95 Lakh margin -10.5%
EBITDA · FY 2024
-₹8.38 Lakh margin -3.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 7%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▼ 27%
5 years · compounded
▼ 19%
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 23% fall in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.58 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹26.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.3% | ||||
| Net Profit Margin | -10.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aries Drugs Private Limited, buy the company report.
Board of directors of Aries Drugs Private Limited
Aries Drugs has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madan Lal Agarwal Also directs: Gemcross Formulation Private Limited | Director | 02 May 2024 | 2 Years 6 Months | Current |
| Ronak Agrawal Also directs: Gemcross Formulation Private Limited | Director | 02 May 2024 | 2 Years 6 Months | Current |
| Hari Om Agarwal | Director | 21 Jan 2019 | 7 Years 9 Months | Current |
| Amit Agarwal Also directs: Maad Labs Biocare LLP | Managing Director | 04 Apr 2005 | 21 Years 6 Months | Current |
Peer comparison
Aries Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maas Herbals Private Limited | ₹2.6 Cr (FY 2016) | -26.0% | Bangalore, Karnataka, India | |||
| Betasys Healthcare Limited | ₹2.58 Cr (FY 2024) | 272.0% | Derabassi, Punjab, India | |||
| Aries Drugs Private Limitedthis company | ₹2.58 Cr (FY 2024) | -₹26.95 Lakh | -10.5% | -23.0% | 21 | Rudrapur, Uttarakhand, India |
| Philan Herbomedix Private Limited | ₹2.57 Cr (FY 2024) | -28.0% | Ahmedabad, Gujarat, India | |||
| Asian Lifecare Private Limited | ₹2.57 Cr (FY 2022) | -8.0% | Savli, Gujarat, India |
To see the full peer comparison of Aries Drugs Private Limited, buy the company report.
Auditor
Aries Drugs Private Limited is audited by HARNAM SINGH & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARNAM SINGH & CO. | FY 2024 | 015827C |
Shareholding
The shareholding of Aries Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aries Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹45 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jul 2008 | 10118420 | Others | ₹45 Lakh | Satisfied |
To see the full charge records of Aries Drugs Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Aries Drugs Private Limited has 26 court cases on record: 9 filed by Aries Drugs, 17 filed against it. 6 cases are pending and 20 are disposed.
Total cases
26
Filed by the company
9
Filed against the company
17
Pending
6
Disposed
20
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 25 | 16 | 6 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Civil suit | Filed by the company against Ms Titan Biotech Limited and 1 other | Disposed |
| District court, Udham Singh Nagar, Uttarakhand | Court case (Original Civil Suits) | Filed against the company by Pearl Polymers Limited | Disposed |
| District court, South East, Delhi | Criminal case | Filed against the company by Radico Khaitan Ltd. | Disposed |
| District court, Udham Singh Nagar, Uttarakhand | Criminal case | Filed by the company against M/S Swaroop Medical Agency | Pending |
| District court, Udham Singh Nagar, Uttarakhand | Court case (Original Civil Suits) | Filed by the company against an individual | Pending |
To see the full case history of Aries Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Aries Drugs Private Limited has 11 MSME Form 1 returns on record between 2013 and 2023, listing 271 overdue payments to 91 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 91)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Friscon India | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Harnam Singh & Co. |
To see the full MSME payment records of Aries Drugs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Aries Drugs Private Limited has a workforce of 21 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
Employee count
21
Active EPFO establishments
1
Employee growth
10.53%
GST
Aries Drugs has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAFCA6166P1Z9 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aries Drugs Private Limited, buy the company report.
Recent activity
Aries Drugs Private Limited has 11 board changes on record since 2005: 4 appointments and 7 cessations. The latest: Malvika Agarwal ceased to be Director on 04 May 2024.
AGM
Aries Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Malvika Agarwal ceased to be Director.
Ceased
Robin Mathew ceased to be Director.
Appointed
Madan Lal Agarwal was appointed as Director.
Appointed
Ronak Agrawal was appointed as Director.
Filing
Aries Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand.
Ceased
Amit Agarwal ceased to be Director.
Appointed
Hari Om Agarwal was appointed as Director.
Ceased
Mukul Agarwal ceased to be Director.
Charges
A charge registered on 18 Jul 2008 via Charge ID 10118420 with Others was fully satisfied on 18 Jun 2018.
Charges
A charge with Others of Rs. 0.45 Cr registered on 18 Jul 2008 with Charge ID 10118420 was modified on 26 Oct 2017.
Ceased
Sushant Rai Agarwal ceased to be Director.
5 earlier events are in the company report.
Frequently asked questions
Aries Drugs is an active private limited company based in Rudrapur, Uttarakhand, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 04 April 2005 (21+ years old) and is registered under CIN U24232UR2005PTC007478.
Aries Drugs has 4 current directors:
- Amit Agarwal - Managing Director
- Madan Lal Agarwal - Director
- Ronak Agrawal - Director
- Hari Om Agarwal - Director
The latest financial statements of Aries Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Aries Drugs is 05AAFCA6166P1Z9, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Aries Drugs is U24232UR2005PTC007478. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aries Drugs has 26 court cases on record: 9 filed by the company and 17 filed against it. 6 are pending. Most are in the district courts.
Aries Drugs was incorporated on 04 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Aries Drugs by revenue are Maas Herbals Private Limited, Betasys Healthcare Limited, Philan Herbomedix Private Limited, Asian Lifecare Private Limited, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Malvika Agarwal ceased to be Director on 04 May 2024. Robin Mathew ceased to be Director on 04 May 2024. Madan Lal Agarwal was appointed as Director on 02 May 2024. Aries Drugs has 11 board changes on record in total.
Yes, Aries Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-12-0002150).
Aries Drugs has 11 MSME Form 1 returns on record between 2013 and 2023, listing 271 overdue payments to 91 micro and small suppliers. The latest return was filed on 04 Sep 2023.
Aries Drugs can be reached through the website ariesdrugs.com. Its registered office is in Rudrapur, Uttarakhand, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages